tm logo

Monitor this mark

View On USPTO

ACHIEVE
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 07 Jun 2024

Last Applicant/ Owned by

Achieve Life Sciences, Inc.

22722 29th Drive SE, Suite 100

Bothell

WA

98021

Serial Number

97229947 filed on 20th Jan 2022

Registration Number

N/A

Correspondent Address

Winfield B. Martin

Winfield B. Martin PERKINS COIE LLP

SEATTLE, WA 98111

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ACHIEVE

Pharmaceutical preparations of cytisinicline and its derivatives for use as an aid for nicotine addiction cessation, smoking cessation, and nicotine e-cigarettes cessation

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations of cytisinicline and its derivatives for use as an aid for nicotine addiction cessation, smoking cessation, and nicotine e-cigarettes cessation

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97229947

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 137319-4001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
20th Nov 2024SOU TEAS EXTENSION RECEIVED
13th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Jun 2024SOU EXTENSION 4 FILED
07th Jun 2024SOU EXTENSION 4 GRANTED
07th Jun 2024SOU TEAS EXTENSION RECEIVED
24th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Nov 2023SOU EXTENSION 3 GRANTED
22nd Nov 2023SOU EXTENSION 3 FILED
22nd Nov 2023SOU TEAS EXTENSION RECEIVED
13th Jun 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED